» Articles » PMID: 34656426

Correlations of Blood and Brain Biochemistry in Phenylketonuria: Results from the Pah-enu2 PKU Mouse

Overview
Journal Mol Genet Metab
Specialty Endocrinology
Date 2021 Oct 17
PMID 34656426
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In phenylketonuria (PKU), treatment monitoring is based on frequent blood phenylalanine (Phe) measurements, as this is the predictor of neurocognitive and behavioural outcome by reflecting brain Phe concentrations and brain biochemical changes. Despite clinical studies describing the relevance of blood Phe to outcome in PKU patients, blood Phe does not explain the variance in neurocognitive and behavioural outcome completely.

Methods: In a PKU mouse model we investigated 1) the relationship between plasma Phe and brain biochemistry (Brain Phe and monoaminergic neurotransmitter concentrations), and 2) whether blood non-Phe Large Neutral Amino Acids (LNAA) would be of additional value to blood Phe concentrations to explain brain biochemistry. To this purpose, we assessed blood amino acid concentrations and brain Phe as well as monoaminergic neurotransmitter levels in in 114 Pah-Enu2 mice on both B6 and BTBR backgrounds using (multiple) linear regression analyses.

Results: Plasma Phe concentrations were strongly correlated to brain Phe concentrations, significantly negatively correlated to brain serotonin and norepinephrine concentrations and only weakly correlated to brain dopamine concentrations. From all blood markers, Phe showed the strongest correlation to brain biochemistry in PKU mice. Including non-Phe LNAA concentrations to the multiple regression model, in addition to plasma Phe, did not help explain brain biochemistry.

Conclusion: This study showed that blood Phe is still the best amino acid predictor of brain biochemistry in PKU. Nevertheless, neurocognitive and behavioural outcome cannot fully be explained by blood or brain Phe concentrations, necessitating a search for other additional parameters.

Take-home Message: Blood Phe is still the best amino acid predictor of brain biochemistry in PKU. Nevertheless, neurocognitive and behavioural outcome cannot fully be explained by blood or brain Phe concentrations, necessitating a search for other additional parameters.

Citing Articles

Impaired cognitive function and decreased monoamine neurotransmitters in the DNAJC12 gene knockout mouse model.

Wang S, Shen M, Pang B, Zhou B, Yuan Y, Lu M Orphanet J Rare Dis. 2025; 20(1):60.

PMID: 39923104 PMC: 11806585. DOI: 10.1186/s13023-025-03580-z.


Impact of Phenylketonuria on the Serum Metabolome and Plasma Lipidome: A Study in Early-Treated Patients.

Weerd J, van Wegberg A, Boer T, Engelke U, Coene K, Wevers R Metabolites. 2024; 14(9).

PMID: 39330486 PMC: 11434371. DOI: 10.3390/metabo14090479.


Compromised white matter is related to lower cognitive performance in adults with phenylketonuria.

Muri R, Maissen-Abgottspon S, Reed M, Kreis R, Hoefemann M, Radojewski P Brain Commun. 2023; 5(3):fcad155.

PMID: 37265600 PMC: 10231812. DOI: 10.1093/braincomms/fcad155.


Protein substitutions as new-generation pharmanutrition approach to managing phenylketonuria.

Keskin F, Sahin T, Capasso R, Agagunduz D Clin Exp Pediatr. 2022; 66(8):320-331.

PMID: 36397260 PMC: 10397997. DOI: 10.3345/cep.2022.00584.


Molecular and Functional Characterization of a Novel Kunitz-Type Toxin-like Peptide in the Giant Triton Snail .

Zhang G, Jia H, Luo L, Zhang Y, Cen X, Yao G Mar Drugs. 2022; 20(11).

PMID: 36355009 PMC: 9695905. DOI: 10.3390/md20110686.